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Abstract: During chronic injury a population of bipotent hepatic
progenitor cells (HPCs) become activated to regenerate both cholan-
giocytes and hepatocytes. Here we show in human diseased liver and
mouse models of the ductular reaction that Notch and Wnt signaling
direct speciﬁcation of HPCs via their interactions with activated
myoﬁbroblasts or macrophages. In particular, we found that during
biliary regeneration, expression of Jagged 1 (a Notch ligand) by myo-
ﬁbroblasts promoted Notch signaling in HPCs and thus their biliary
speciﬁcation to cholangiocytes. Alternatively, during hepatocyte
regeneration, macrophage engulfment of hepatocyte debris induced
Wnt3a expression. This resulted in canonical Wnt signaling in nearby
HPCs, thus maintaining expression of Numb (a cell fate determinant)
within these cells and the promotion of their speciﬁcation to hepato-
cytes. By these two pathways adult parenchymal regeneration dur-
ing chronic liver injury is promoted.
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of apoptosis; HNF-1b, hepatocyte nuclear factor-1b.In spite of the impressive regenerative potential of the liver as
a result of the mitogenic capabilities of hepatocytes and cholan-
giocytes, liver repair often involves progenitor cells (HPC). This
bipotent cell population, barely identiﬁable in normal livers,
expands following liver injury. Depending on the type of damage
including its acute or chronic nature, HPC may differentiate into
mature cholangiocytes, hepatocytes or into a population of small
cytokeratin 19-positive epithelial cells exhibiting cholangiocyte
phenotypic markers that arrange themselves into tubeless struc-
tures. These ‘‘activated’’ (or ‘‘reactive’’) cholangiocytes express an
array of inﬂammatory mediators as well as cytokines and their
cognate receptors, and thus are able to orchestrate the functions
of several cell types centered around the repair of the epithelial
wound. Expansion of activated cholangiocytes is associated with
persistent inﬂammation, mesenchymal cell activation, portal
ﬁbrosis and progression of liver disease [1–3].
While the mechanisms leading to the expansion of the HPC
compartment are still unclear, a seminal paper recently pub-
lished in the April issue of Nature Medicine addresses the mecha-
nisms of HPC speciﬁcation in chronic liver diseases [4]. This
elegant work demonstrates that HPC speciﬁcation differs accord-
ing to which liver epithelial compartment (hepatocellular or bil-
iary) is predominantly damaged and the consequent changes
within the progenitor cell niche. It proposes the intriguing
hypothesis that the switch is represented by two alternatively
acting developmental mechanisms, canonical Wnt/b-catenin sig-
naling or Notch signaling (Fig. 1).
Boulter et al. show that hepatocellular speciﬁcation of HPC is
determined by the release of Wnt3a by macrophages after phago-
cytosis of cellular debris from damaged hepatocytes. Wnt3a then
acts on HPC to stimulate the nuclear translocation of b-catenin
and its signaling. Wnt/b-catenin/T-cell-speciﬁc transcription fac-
tor/lymphoid enhancer-binding factor-1 (TCF/LEF-1) signaling is
known to participate in several steps of bile duct development.
Earlier works by Hu et al. have shown that Wnt3a is able to stim-
ulate the proliferative activity of HPC in vitro, and, different from
Boulter et al., activation of canonical Wnt/b-catenin signaling is
evident in proliferating HPC in mice in vivo also following the
administration of 3,5-diethoxycarbonyl-1,4-dihydrocollidine
(DDC), a model of ductular reaction induced by obstructive cho-
lestasis derived from precipitation of protoporphyrins within
the intrahepatic bile ducts [5]. It is important to note that HPC
behavior appears to be strongly model- and time-dependent.
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Fig. 1. Epithelial–stromal interactions behave as critical regulators of liver repair mechanisms in response to biliary or hepatocellular damage. By alternatively
activating Notch and Wnt signaling, the stroma microenvironment orchestrates the divergent speciﬁcation of HPC towards the biliary or hepatocellular lineage,
respectively. In biliary regeneration, the interaction of HPC with myoﬁbroblasts expressing Jagged1 results in the activation of Notch2 in HPC, leading to their biliary
speciﬁcation (red left-sided section). In contrast, during hepatocellular regeneration, HPC are activated by Wnt3a released by macrophages in response to phagocytosis of
debris from apoptotic hepatocytes. Wnt3a then stimulates the nuclear translocation of b-catenin, which promotes HPC differentiation towards the hepatocellular lineage
(green right-sided section). In this bimodal crosstalk between HPC and adjacent inﬂammatory stromal cells, Numb plays a key role as ‘‘switcher’’. HPC differentiation into
mature cholangiocytes or hepatocytes leads to resolution. When these mechanisms fail, reactive cholangiocytes are activated in conjunction with persistent inﬂammation,
mesenchymal cell activation, and portal ﬁbrosis, ultimately leading to progression of liver disease (pathologic repair, center-sided section).
International Hepatologyliver carcinogenetic diet that promotes the emergence of a large
number of proliferating oval cells, expressing albumin and a-
fetoprotein, with little parenchymal necrosis. As originally shown
by Guest et al., small ductules are formed by HPC after 10 weeks
of CDE treatment [6]. Thus, it remains unclear whether the HPC
(or oval cells) that accumulate during a CDE diet are en route
to become hepatocytes or ‘‘activated’’ cholangiocytes or both.
A major novelty of the recent Nature Medicine paper is the role
of Numb. Numb is a target of canonical Wnt signaling and its acti-
vation by Wnt3a has several consequences, including Notch
receptor inhibition at the level of the intracellular domains [7],
and inhibition of Hedgehog signaling [8], another major mecha-
nism of biliary repair [2,3]. Boulter et al. present circumstantial
evidence that speciﬁcation of HPC is determined by a direct
cell–cell interaction between Notch-expressing HPC and Jagged-
1-expressing mesenchymal cells and hypothesize that this would
be the default speciﬁcation pathway for HPC in the absence of
inﬁltrating macrophages and Wnt/b-catenin signaling [4].
Thus, macrophage-derivedWnt inhibits a default-activated Notch182 Journal of Hepatology 201signaling via Numb, allowing HPC to escape the biliary cell fate
and acquire an hepatocellular speciﬁcation. By alternatively
activating Notch or Wnt/b-catenin signaling, myoﬁbroblasts and
macrophages orchestrate the divergent speciﬁcation of HPC
towards the biliary or hepatocellular lineage, respectively [4].
This seminal work certainly raises a number of open ques-
tions, worth being addressed in further studies. For example,
the proposed role of macrophages in HPC speciﬁcation towards
the hepatocellular phenotype deserves further investigation. Par-
acrine factors secreted by macrophages have been previously
shown to affect the HPC compartment. For example, the tumor
necrosis factor-like weak inducer of apoptosis (TWEAK), a mem-
ber of the tumor necrosis factor (TNF)-a family and produced by
natural killer cells and macrophages, induces a selective expan-
sion of HPC in both DDC and CDE toxicity models [9,10]. In liver
repair, the functions of macrophages strongly depend on their
phenotype. Alternatively-activated rather than classically-acti-
vated macrophages are key drivers of abnormal liver reparative
processes leading to excessive deposition of matrix [11]. There-3 vol. 58 j 181–183
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fore, phenotypic characterization of macrophages engaged in the
crosstalk with the HPC compartment as well as the time frame of
these interactions will provide additional insights into their role
in HPC commitment.
Earlier work in Alagille syndrome (a ductopenic cholangiopa-
thy caused by a genetic defect in Notch signaling) has shown that
when Notch signaling is defective, hepatocyte nuclear factor
(HNF)-1b, a transcription factor critical for biliary speciﬁcation,
is downregulated and HPC are forced towards the intermediate
hepatocyte fate instead of the biliary fate [12]. Boulter et al. fur-
ther suggest that Notch is a default inducer of biliary speciﬁcation
that can be activated by interaction with myoﬁbroblasts. These
conclusions rely on gene expression studies and on the use of
Notch inhibitors that have several off-target effects. Thus, genetic
models of Notch loss/gain of function will be needed to prove the
relative role of Notch-1/Notch-2 in biliary speciﬁcation during
liver repair. As shown during development, the role of Notch
may go well beyond HPC speciﬁcation and involve branching
tubular morphogenesis [13]. Effective biliary repair requires the
formation of biliary tubules and regeneration of the branching
architecture of the ductal system. If a proper branching structure
is not regenerated, the ﬁnal result will be parenchymal necrosis
or vanishing bile duct syndrome and ﬁbrosis, i.e., the ﬁnal stage
of several cholangiopathies. As Boulter’s paper reminds us, liver
repair is a complex mechanism that requires the concerted activ-
ities of several developmental mechanisms and interactions
among multiple cell types. Understanding the role of Notch,
Wnt and other morphogens in the regulation of biliary repair is
a journey that has just begun, but solving this puzzle will gener-
ate signiﬁcant beneﬁts for liver patients.Conﬂict of interest
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